Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ArQule (ARQL)

ArQule Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARQL
DateTimeSourceHeadlineSymbolCompany
14/02/202022:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARQLArQule Inc
14/02/202017:20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARQLArQule Inc
12/02/202022:03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARQLArQule Inc
12/02/202017:05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARQLArQule Inc
10/02/202018:43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARQLArQule Inc
05/02/202016:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARQLArQule Inc
27/01/202018:55Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ARQLArQule Inc
21/01/202011:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARQLArQule Inc
21/01/202011:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARQLArQule Inc
21/01/202011:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARQLArQule Inc
06/01/202016:07PR Newswire (US)Moore Kuehn, PLLC Encourages Investors of KEM, ARQL, THOR, and LOGM to Contact the FirmNASDAQ:ARQLArQule Inc
12/12/201920:49PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates ArQule, Inc.NASDAQ:ARQLArQule Inc
10/12/201908:02Dow Jones NewsMerck, Sanofi Push To Add Cancer Drugs -- WSJNASDAQ:ARQLArQule Inc
10/12/201900:16Dow Jones NewsBig Drugmakers Push Deeper Into Cancer Treatment -- 4th UpdateNASDAQ:ARQLArQule Inc
09/12/201921:37Dow Jones NewsBig Drugmakers Push Deeper Into Cancer Treatment -- 3rd UpdateNASDAQ:ARQLArQule Inc
09/12/201920:12Dow Jones NewsU.S. Stocks Slip as Trade War Weighs on Chinese ExportsNASDAQ:ARQLArQule Inc
09/12/201919:33Dow Jones NewsBig Drugmakers Push Deeper Into Cancer Treatment -- 2nd UpdateNASDAQ:ARQLArQule Inc
09/12/201916:13Dow Jones NewsMerck to Buy ArQule for $2.7 Billion -- UpdateNASDAQ:ARQLArQule Inc
09/12/201913:05Business WireArQule Announces Final Phase 1 Clinical Data for Its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology...NASDAQ:ARQLArQule Inc
09/12/201912:37PR Newswire (US)(ARQL) Alert: Johnson Fistel Investigates Proposed Sale of ArQule, Inc.; Is $20 a Fair Price?NASDAQ:ARQLArQule Inc
09/12/201912:26Dow Jones NewsMerck to Buy ArQule for $2.7 Billion, or $20/ShareNASDAQ:ARQLArQule Inc
09/12/201911:45Business WireMerck to Acquire ArQule, Advancing Leadership in OncologyNASDAQ:ARQLArQule Inc
25/11/201912:00Business WireArQule to Present Clinical Data for its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology 2019 Annual ...NASDAQ:ARQLArQule Inc
13/11/201912:00Business WireArQule to Participate in the Jefferies London Healthcare Conference on November 20, 2019NASDAQ:ARQLArQule Inc
06/11/201914:05Business WireArQule Announces Release of American Society of Hematology Abstract Detailing Results of the Ongoing Phase 1 Study of Reversi...NASDAQ:ARQLArQule Inc
30/10/201914:57Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARQLArQule Inc
30/10/201911:30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARQLArQule Inc
30/10/201911:00Business WireArQule Reports Third Quarter 2019 Financial ResultsNASDAQ:ARQLArQule Inc
29/10/201920:01Business WireArQule Presents Recent Data on ARQ 751 at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets & Cancer Ther...NASDAQ:ARQLArQule Inc
21/10/201911:00Business WireArQule Announces Preclinical Data Demonstrating Potential of Miransertib (ARQ 092) to Treat PIK3CA-Driven Vascular Malformati...NASDAQ:ARQLArQule Inc
 Showing the most relevant articles for your search:NASDAQ:ARQL